首页> 美国卫生研究院文献>other >Preimplantation Genetic Diagnosis for a Chinese Family with Autosomal Recessive Meckel-Gruber Syndrome Type 3 (MKS3)
【2h】

Preimplantation Genetic Diagnosis for a Chinese Family with Autosomal Recessive Meckel-Gruber Syndrome Type 3 (MKS3)

机译:中国家庭常染色体隐性Meckel-Gruber综合征3型(MKS3)的植入前遗传学诊断。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Meckel-Gruber syndrome type 3 is an autosomal recessive genetic defect caused by mutations in TMEM67 gene. In our previous study, we have identified a homozygous TMEM67 mutation in a Chinese family exhibiting clinical characteristics of MKS3, which provided a ground for further PGD procedure. Here we report the development and the first clinical application of the PGD for this MKS3 family. Molecular analysis protocol for clinical PGD procedure was established using 50 single cells in pre-clinical set-up. After whole genomic amplification by multiple displacement amplification with the DNA from single cells, three techniques were applied simultaneously to increase the accuracy and reliability of genetic diagnosis in single blastomere, including real-time PCR with Taq Man-MGB probe, haplotype analysis with polymorphic STR markers and Sanger sequencing. In the clinical PGD cycle, nine embryos at cleavage-stage were biopsied and subjected to genetic diagnosis. Two embryos diagnosed as free of TMEM67 mutation were transferred and one achieving normal pregnancy. Non-invasive prenatal assessment of trisomy 13, 18 and 21 by multiplex DNA sequencing at 18 weeks’ gestation excluded the aneuploidy of the analyzed chromosomes. A healthy boy was delivered by cesarean section at 39 weeks’ gestation. DNA sequencing from his cord blood confirmed the result of genetic analysis in the PGD cycle. The protocol developed in this study was proved to be rapid and safe for the detection of monogenic mutations in clinical PGD cycle.
机译:Meckel-Gruber综合征3型是由TMEM67基因突变引起的常染色体隐性遗传缺陷。在我们以前的研究中,我们已经鉴定出中国家庭中具有MKS3临床特征的纯合子TMEM67突变,这为进一步的PGD手术奠定了基础。在这里,我们报告该MKS3家族的PGD的开发和首次临床应用。使用临床前设置中的50个单细胞建立了用于临床PGD程序的分子分析方案。在通过单细胞DNA的多重置换扩增进行全基因组扩增后,同时应用了三种技术来提高单个卵裂球基因诊断的准确性和可靠性,包括Taq Man-MGB探针的实时PCR,多态性STR的单倍型分析标记和Sanger测序。在临床PGD周期中,对处于分裂期的9个胚胎进行活检并进行基因诊断。转移了两个没有TMEM67突变的胚胎,其中一个实现了正常怀孕。在妊娠18周时通过多重DNA测序对13号,18号和21号三体进行非侵入式产前评估,排除了所分析染色体的非整倍性。一个健康的男孩在妊娠39周时被剖宫产。他脐带血的DNA测序证实了PGD循环中遗传分析的结果。事实证明,本研究开发的方案可快速安全地检测临床PGD周期中的单基因突变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号